DocuSign 8-K: Executive/Director Changes Reported Jan 9, 2024
Ticker: DOCU · Form: 8-K · Filed: Jan 16, 2024 · CIK: 1261333
| Field | Detail |
|---|---|
| Company | Docusign, Inc. (DOCU) |
| Form Type | 8-K |
| Filed Date | Jan 16, 2024 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.0001, $525,000 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: executive-changes, corporate-governance, compensation
TL;DR
**DocuSign filed an 8-K about executive changes on Jan 9, watch for details on leadership shifts.**
AI Summary
DocuSign, Inc. filed an 8-K on January 16, 2024, reporting an event that occurred on January 9, 2024, related to changes in its executive team or director compensation. This filing is important for investors because it signals potential shifts in leadership or executive incentives, which can impact the company's strategic direction and financial performance. Any changes in key personnel or their compensation structures could influence investor confidence and the stock's future trajectory.
Why It Matters
Changes in executive leadership or compensation can significantly alter a company's strategy and operational focus, directly affecting its stock valuation and future growth prospects.
Risk Assessment
Risk Level: medium — The filing indicates changes in leadership or compensation, which can introduce uncertainty but also opportunities, making it a medium risk event.
Analyst Insight
Investors should closely monitor subsequent filings or press releases from DocuSign for specific details regarding the reported changes in directors, officers, or compensatory arrangements, as these will provide clarity on the impact to the company's future direction and valuation.
Key Numbers
- $0.0001 — par value per share (This is the nominal value assigned to each share of DocuSign's Common Stock.)
Key Players & Entities
- DOCUSIGN, INC. (company) — the registrant filing the 8-K
- January 9, 2024 (date) — date of the earliest event reported
- January 16, 2024 (date) — date the 8-K was filed
- 001-38465 (other) — Commission File Number
- Delaware (other) — State of Incorporation for DocuSign
- 91-2183967 (other) — I.R.S. Employer Identification Number for DocuSign
- 221 Main St. Suite 1550 San Francisco California 94105 (other) — Address of Principal Executive Offices for DocuSign
- 415-489-4940 (other) — Registrant's Telephone Number for DocuSign
- Common Stock, par value $0.0001 per share (other) — Title of each class of securities registered
- DOCU (other) — Trading Symbol for DocuSign
FAQ
What was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 9, 2024, as stated in the 'Date of Report (Date of earliest event reported)' section.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on January 16, 2024, as indicated by the 'FILED AS OF DATE' and 'Date of Report' sections.
What specific items are covered by this 8-K filing, according to the 'ITEM INFORMATION'?
The 'ITEM INFORMATION' section specifies that this 8-K covers 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers'.
What is DocuSign, Inc.'s trading symbol and on which exchange is its common stock registered?
DocuSign, Inc.'s trading symbol is DOCU, and its Common Stock, par value $0.0001 per share, is registered on The Nasdaq Global Select Market.
What is the business address and phone number for DocuSign, Inc. as listed in the filing?
DocuSign, Inc.'s business address is 221 Main St. Suite 1550, San Francisco, California 94105, and its business phone number is (415) 489-4940.
Filing Stats: 1,870 words · 7 min read · ~6 pages · Grade level 13.5 · Accepted 2024-01-16 16:10:35
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share DOCU The Nasdaq Global Select
- $525,000 — ive release of claims: (i) a payment of $525,000 as cash severance, which amount represe
Filing Documents
- docu-20240109.htm (8-K) — 72KB
- exhibit101_suhseparationag.htm (EX-10.1) — 78KB
- exhibit102_formofarexecuti.htm (EX-10.2) — 113KB
- 0001261333-24-000008.txt ( ) — 427KB
- docu-20240109.xsd (EX-101.SCH) — 2KB
- docu-20240109_lab.xml (EX-101.LAB) — 24KB
- docu-20240109_pre.xml (EX-101.PRE) — 13KB
- docu-20240109_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 10.1 Separation Agreem ent by and between DocuSign, Inc. and Inhi Cho Suh, dated January 16 , 2024. 10.2 Form of Amended and Restated Executive Severance and Change in Control Agreement. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: January 16, 2024 DOCUSIGN, INC. By: /s/ James P. Shaughnessy James P. Shaughnessy Chief Legal Officer